Pharmafile Logo
Pharmafocus logo
Advanced Search

Simponi

Showing 11 posts of 11 posts found.

NICE recommends hep C and bowel treatments

February 26, 2015
Sales and Marketing AbbVie, Humira, J&J, JJ, Janssen, Merck, Remicade, Simponi, olysio

Three drugs to treat chronic bowel condition ulcerative colitis and one for hepatitis C will be funded by the NHS …

News
janssen image

Janssen abandons Simponi application

May 23, 2014
Sales and Marketing Europe, Janssen, RA, Simponi, rheumatoid arthritis

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

News
Merck image

Merck: ‘2014 revenues will be down’

February 7, 2014
Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results

Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …

News

MSD sways NICE with Simponi patient access scheme

August 26, 2011
Sales and Marketing NICE, Simponi, ankylosing spondylitis

A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …

News

Price concession helps change NICE’s mind on Simponi

May 13, 2011
Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme

NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

News
Arthritis drug Remicade

J&J and Merck reach compromise on arthritis drug rights

April 19, 2011
Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi

Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …

News
Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

News

J&J hit by another string of product recalls

February 21, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls

There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …

News

Ulcerative colitis market set to double by 2018

February 12, 2010
Sales and Marketing Humira, Simponi, TNF, ulcerative colitis

The market for ulcerative colitis drugs is set to double over the ten years to 2018 when it will hit …

News

Simponi approved in Europe

October 8, 2009
Sales and Marketing RA, Simponi, TNF

 Rheumatic disease drug Simponi has received marketing approval for Europe, where it will be marketed by Schering-Plough.The drug is indicated …

News

Simponi approved in Canada

April 16, 2009
Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026